Jane Street
BCYC

Jane Street’s Bicycle Therapeutics BCYC Stock Holding History

Jane Street’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-93,000
Closed -$1.68M – 9176
2023
Q4 		$1.68M Buy
93,000
+3,900
+4% +$64.5K ﹤0.01% 4635
2023
Q3 		$1.79M Buy
+89,100
New +$2.04M ﹤0.01% 4247
2022
Q2 		– Sell
-5,700
Closed -$250K – 9650
2022
Q1 		$250K Buy
+5,700
New +$266K ﹤0.01% 8684

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's BCYC Position: Q1 2026 in Review

Jane Street increased its Bicycle Therapeutics (BCYC) stake by 245% in Q1 2026, buying an estimated $885K and bringing the position to 218,115 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #6476.

Jane Street first reported a position in BCYC in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.5M in Q4 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Jane Street held 218,115 shares of Bicycle Therapeutics worth $1.01M as of Q1 2026.
  • Jane Street bought 154,925 Bicycle Therapeutics shares in Q1 2026, an estimated $885K.
  • Bicycle Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6476 holding.
  • Jane Street first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 13 quarters since.
  • Jane Street's Bicycle Therapeutics position peaked at $1.5M in Q4 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.